ResMed Reorganizes, Restructures Management

SAN DIEGO — Sleep sector giant ResMed has announced a reorganization and restructuring of management "that will strengthen our focus on the key drivers for ResMed's future growth, improve our ability to deliver in these areas and result in more effective investment initiatives," according to Chairman and CEO Peter C. Farrell, PhD.

Farrell, who founded ResMed in 1989, moved back into the CEO position in February on the departure of Kieran T. Gallahue, who left to become chairman and CEO of CareFusion, a medical technology company that focuses on the hospital sector.

Since then, Farrell said, he has reevaluated ResMed's strategy and organization.

"We are dedicated to providing innovative solutions that meet the needs of our sleep-disordered breathing patients and our distributors. We are also passionate about addressing the widespread ignorance which exists concerning the strong correlation between untreated SDB and such co-morbidities as cardiac disease, metabolic syndrome/type 2 diabetes, chronic obstructive pulmonary disease, perioperative risk, and occupational health and safety," Farrell said in a May 23 release.

"We have clinical data to show that treating SDB with nasal CPAP actually ameliorates and, in some cases, reverses the complications associated with these disease states, when SDB is present," he continued. "To this end, we have elected to reorganize certain business units and management responsibilities to more effectively align our activities with our strategic goals."

ResMed's new structure, which combines three existing business units into two and creates a new strategic business unit, repositions current senior executives without adding new hires, the company said. Here's a rundown from the release:

• The company is aligning its strategic business units to take advantage of scale and efficiency. Don Darkin will head a combination of the former sleep and patient interface organizations as president of the SDB strategic business unit, which is responsible for product development and marketing. Darkin was formerly senior vice president, patient interface strategic business unit.

  Geoff Neilson becomes president of the newly created respiratory care strategic business unit, which will focus on COPD. He was formerly vice president, ventilation strategic business unit.